We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Bevacizumab and Retinal Vascular Occlusions

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified June 2006 by Asociación para Evitar la Ceguera en México.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT00347711
First Posted: July 4, 2006
Last Update Posted: July 4, 2006
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Asociación para Evitar la Ceguera en México
  Purpose
To evaluate the effects of Intravitreal Bevacizumab in macular edema in retinal vascular occlusion.

Condition Intervention Phase
Edema Macular Vascular Occlusion Drug: Intravitreal injection Phase 3

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)

Resource links provided by NLM:


Further study details as provided by Asociación para Evitar la Ceguera en México:

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   40 Years to 90 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Criteria

Inclusion Criteria:

  • Vascular occlusion and edema macular diagnosticated by fluorescein angiography and coherent optic tomography

Exclusion Criteria:

  • Previous surgery
  • Uveitis
  • Glaucoma
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00347711


Locations
Mexico
Asociacion para Evitar la Ceguera en Mexico Recruiting
Mexico, D.F. Mexico, Mexico, 04030
Contact: Griselda Alvarez, Fellow    5255 10841400 ext 1171    retinamex@yahoo.com.   
Sponsors and Collaborators
Asociación para Evitar la Ceguera en México
Investigators
Principal Investigator: Griselda Alvarez, Fellow APEC
  More Information

ClinicalTrials.gov Identifier: NCT00347711     History of Changes
Other Study ID Numbers: APEC-0020
First Submitted: June 30, 2006
First Posted: July 4, 2006
Last Update Posted: July 4, 2006
Last Verified: June 2006

Additional relevant MeSH terms:
Macular Edema
Macular Degeneration
Retinal Degeneration
Retinal Diseases
Eye Diseases